Glenmark Pharmaceuticals ltd — Call Transcript 2023

Nov 20, 2023

==> picture [33 x 32] intentionally omitted <==

==> picture [148 x 45] intentionally omitted <==

November 20, 2023

To, To, Dy. General Manager The Manager – Listing, Department of Corporate Services, National Stock Exchange of India Ltd., BSE Ltd., Plot No. C/1, G Block, P. J. Towers, Dalal Street, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051

Ref: Scrip Code: 532296

Ref: Scrip Name: GLENMARK

Dear Sirs,

Sub: Transcript of the Earnings Call

Further to our letter dated 6th November, 2023 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (LODR), Regulations 2015, the transcript of the Earnings call held on Wednesday, November 15, 2023 for the second quarter and half year ended - September 30, 2023 has been uploaded on the Company’s website at https://glenmark.b - cdn.net/gpl_pdfs/investors/reports_presentations/earning_concall/GlenmarkPharma Earnings%20Call%20Transcript-15Nov-2023.pdf.

Request you to kindly take the same on record.

Thanking you.

Yours faithfully, For Glenmark Pharmaceuticals Limited

HARISH Digitally signed by HARISH VINAYAK VINAYAK KUBER Date: 2023.11.20 KUBER 16:06:47 +05'30' Harish Kuber

Company Secretary & Compliance Officer

Tel: 4018 9999 / 4018 9879 Fax: 4018 9986 (Legal & Secretarial Dept.)

Glenmark Pharmaceuticals Ltd. Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com